Bladder carcinoma: Where are the patient advocates?

Cancer

Volumn 104, Issue 8, 2005, Pages 1559-1562

  Soloway, Mark S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CARCINOMA; CANCER RECURRENCE; CIGARETTE SMOKING; CYSTOSCOPY; HUMAN; PATIENT EDUCATION; PRIORITY JOURNAL; REVIEW;

HUMANS; PATIENT ADVOCACY; URINARY BLADDER NEOPLASMS;

EID: 26444487269     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21351     Document Type: Review

References (16)

1. Prout GR Jr., Wesley MN, Yancik R, Ries LAG, Havlik RJ, Edwards BK. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer. 2005;104:1638-1647.
2. Messing EM, Catalona W. Urothelial tumors of the urinary tract. In: Vaughan EDJ, editor. Campbell's urology. 7th ed., vol. 3. Philadelphia: W.B. Saunders Company, 1998:2327-2410.
3. Kim HL, Steinberg GD. The current status of bladder preservation in the treatment of muscle invasive bladder cancer. J Urol. 2000;164:627-632.
4. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666-675.
5. Chang SS, Alberts G, Cookson MS, Smith JA Jr. Radical cystectomy is safe in elderly patients at high risk. J Urol. 2001;166:938-941.
6. Clark PE, Stein JP, Groshen SH, et al. Radical cystectomy in the elderly. Cancer. 2005;103:546-552.
7. Soloway MS, Sofer M, Vaidya A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J Urol. 2002;167:1573-1583.
8. Nieder AM, Brausi M, Lamm D, O'Donnell M, et al. SIU/ICUD 2004 International Consensus Conference on bladder cancer: T1 report. Urology. In press.
9. Wallace DMA., Byan RT, Dunn JA, et al. Delay and survival in bladder cancer. BJU Int. 2002;89:868-878.
10. Mahmud SM, Fahmy N, Fong BC, et al. Effect of perioperative delay on survival of bladder cancer patients in Quebec: population based study [abstract]. J Urol. 2005;173:50.
11. Lokeshwar VB, Soloway MS. Current bladder tumor tests: does their projected utility fulfill clinical necessity? J Urol. 2001;165:1067-1077.
12. Soloway MS. Do we have a prostate specific antigen for bladder cancer? [editorial]. J Urol. 1999;161:447-448.
13. Agency for Healthcare Research and Quality. Screening for bladder cancer: update of the evidence for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, 2004. Available from URL: www.preventiveservices.ahrq.gov [accessed 2005].
14. Mayfield MP, Whelan P. Bladder tumors detected on screening results at 7 years. Br J Urol. 1998;82:825-828.
15. Vaidya A, Soloway MS, Hawke C, Tiguert R, Civantos F. De novo muscle invasive bladder cancer: is there a change in trend? J Urol. 2000;165:47-50.
16. Mungan NA, Aben KKH, Schoenberg M, et al. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000;55:876-880.